The median concentrations of most of the parameters studied by our research team were higher in the sera of the CRC patients (CCL2, CCL4, CCL15, CCL24, CCR3, CXCL5, CXCL16, CEA and CRP), but not all of these differences were statistically significant. The gene discussed is CCL2; the disease is colorectal carcinoma.